{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:53:18Z","timestamp":1787741598201,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,4]]},"DOI":"10.7759\/cureus.48252","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T09:33:40Z","timestamp":1699090420000},"source":"Crossref","is-referenced-by-count":32,"title":["An In-Depth Look Into the Epidemiological and Etiological Aspects of Prostate Cancer: A Literature Review"],"prefix":"10.7759","author":[{"given":"Munir","family":"Al-Ghazawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Amo-Afful","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seren","family":"Khasawneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214257","article-title":"Complexities of prostate cancer","volume":"23","author":"Wasim S","year":"2022","unstructured":"Wasim S, Lee SY, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022, 23:10.3390\/ijms232214257","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","unstructured":"Suspected cancer. recognition and referral. (2015). Accessed: November 2023: https:\/\/www.nice.org.uk\/guidance\/ng12."},{"key":"ref4","unstructured":"Cancer research UK . Prostate Cancer. (2022). Accessed: November 2023: https:\/\/www.cancerresearchuk.org\/about-cancer\/prostate-cancer."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0766-1","article-title":"Prostate cancer in primary care","volume":"35","author":"Merriel SW","year":"2018","unstructured":"Merriel SW, Funston G, Hamilton W. Prostate cancer in primary care. Adv Ther. 2018, 35:1285-94. 10.1007\/s12325-018-0766-1","journal-title":"Adv Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34433","article-title":"Racial disparities in Black men with prostate cancer: a literature review","volume":"128","author":"Lillard JW Jr","year":"2022","unstructured":"Lillard JW Jr, Moses KA, Mahal BA, George DJ. Racial disparities in Black men with prostate cancer: a literature review. Cancer. 2022, 128:3787-95. 10.1002\/cncr.34433","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001-2017","volume":"69","author":"Siegel DA","year":"2020","unstructured":"Siegel DA, O'Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001-2017. MMWR Morb Mortal Wkly Rep. 2020, 69:1473-80. 10.15585\/mmwr.mm6941a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia G","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, et al.. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021, 4:877-92. 10.1016\/j.euo.2021.09.006","journal-title":"Eur Urol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00442-8","article-title":"Epidemiology and genomics of prostate cancer in Asian men","volume":"18","author":"Zhu Y","year":"2021","unstructured":"Zhu Y, Mo M, Wei Y, et al.. Epidemiology and genomics of prostate cancer in Asian men. Nat Rev Urol. 2021, 18:282-301. 10.1038\/s41585-021-00442-8","journal-title":"Nat Rev Urol"},{"key":"ref10","article-title":"Prostate cancer incidence and mortality in rural men--a systematic review of the literature","volume":"12","author":"Obertova Z","year":"2012","unstructured":"Obertova Z, Brown C, Holmes M, Lawrenson R. Prostate cancer incidence and mortality in rural men--a systematic review of the literature. Rural Remote Health. 2012, 12:2039.","journal-title":"Rural Remote Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000473828","article-title":"Incidence of prostate cancer will double by the year 2030: the argument for","volume":"29 Suppl 2","author":"Boyle P","year":"1996","unstructured":"Boyle P, Maisonneuve P, Napalkov P. Incidence of prostate cancer will double by the year 2030: the argument for. Eur Urol. 1996, 29 Suppl 2:3-9. 10.1159\/000473828","journal-title":"Eur Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.23938\/ASSN.0123","article-title":"Prostate cancer incidence and mortality in Navarre (Spain)","volume":"41","author":"Etxeberria J","year":"2018","unstructured":"Etxeberria J, Guevara M, Moreno-Iribas C, et al.. Prostate cancer incidence and mortality in Navarre (Spain). An Sist Sanit Navar. 2018, 41:9-15. 10.23938\/ASSN.0123","journal-title":"An Sist Sanit Navar"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel RL","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022, 72:7-33. 10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt151","article-title":"Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men","volume":"105","author":"Zlotta AR","year":"2013","unstructured":"Zlotta AR, Egawa S, Pushkar D, et al.. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J Natl Cancer Inst. 2013, 105:1050-8. 10.1093\/jnci\/djt151","journal-title":"J Natl Cancer Inst"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13593","article-title":"Epidemiology of prostate cancer in Asian countries","volume":"25","author":"Kimura T","year":"2018","unstructured":"Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018, 25:524-31. 10.1111\/iju.13593","journal-title":"Int J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar CH","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018, 8:10.1101\/cshperspect.a030361","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-202993","article-title":"Young-age prostate cancer","volume":"68","author":"Hussein S","year":"2015","unstructured":"Hussein S, Satturwar S, Van der Kwast T. Young-age prostate cancer. J Clin Pathol. 2015, 68:511-5. 10.1136\/jclinpath-2015-202993","journal-title":"J Clin Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030387","article-title":"Prostate cancer disparities by race and ethnicity: from nucleotide to neighborhood","volume":"8","author":"Rebbeck TR","year":"2018","unstructured":"Rebbeck TR. Prostate cancer disparities by race and ethnicity: from nucleotide to neighborhood. Cold Spring Harb Perspect Med. 2018, 8:10.1101\/cshperspect.a030387","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000019909","article-title":"Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility","volume":"35","author":"Ross RK","year":"1999","unstructured":"Ross RK, Coetzee GA, Pearce CL, et al.. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Eur Urol. 1999, 35:355-61. 10.1159\/000019909","journal-title":"Eur Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-018-0081-6","article-title":"Estrogens and prostate cancer","volume":"22","author":"Dobbs RW","year":"2019","unstructured":"Dobbs RW, Malhotra NR, Greenwald DT, Wang AY, Prins GS, Abern MR. Estrogens and prostate cancer. Prostate Cancer Prostatic Dis. 2019, 22:185-94. 10.1038\/s41391-018-0081-6","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-008-9440-x","article-title":"Insulin: a novel agent in the pathogenesis of prostate cancer","volume":"41","author":"Nandeesha H","year":"2009","unstructured":"Nandeesha H. Insulin: a novel agent in the pathogenesis of prostate cancer. Int Urol Nephrol. 2009, 41:267-72. 10.1007\/s11255-008-9440-x","journal-title":"Int Urol Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.140","article-title":"Ethnicity and ERG frequency in prostate cancer","volume":"15","author":"Sedarsky J","year":"2018","unstructured":"Sedarsky J, Degon M, Srivastava S, Dobi A. Ethnicity and ERG frequency in prostate cancer. Nat Rev Urol. 2018, 15:125-31. 10.1038\/nrurol.2017.140","journal-title":"Nat Rev Urol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.11.076","article-title":"Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer","volume":"181","author":"Mononen N","year":"2009","unstructured":"Mononen N, Schleutker J. Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer. J Urol. 2009, 181:1541-9. 10.1016\/j.juro.2008.11.076","journal-title":"J Urol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4155\/fso.15.87","article-title":"Germline genetic profiling in prostate cancer: latest developments and potential clinical applications","volume":"2","author":"Ahmed M","year":"2016","unstructured":"Ahmed M, Eeles R. Germline genetic profiling in prostate cancer: latest developments and potential clinical applications. Future Sci OA. 2016, 2:FSO87. 10.4155\/fso.15.87","journal-title":"Future Sci OA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.2.377","article-title":"Prostate cancer in a patient with a family history of BRCA mutation: a case report and literature review","volume":"32","author":"Song WH","year":"2017","unstructured":"Song WH, Kim SH, Joung JY, Park WS, Seo HK, Chung J, Lee KH. Prostate cancer in a patient with a family history of BRCA mutation: a case report and literature review. J Korean Med Sci. 2017, 32:377-81. 10.3346\/jkms.2017.32.2.377","journal-title":"J Korean Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","unstructured":"Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999, 91.1310-6. 10.1093\/jnci\/91.15.1310","journal-title":"J Natl Cancer Inst"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-020-01389-8","article-title":"Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study","volume":"32","author":"Jenkins KR","year":"2021","unstructured":"Jenkins KR, Oyekunle T, Howard LE, Wiggins EK, Freedland SJ, Allott EH. Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study. Cancer Causes Control. 2021, 32:337-46. 10.1007\/s10552-020-01389-8","journal-title":"Cancer Causes Control"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041447","article-title":"Influence of diet and nutrition on prostate cancer","volume":"21","author":"Matsushita M","year":"2020","unstructured":"Matsushita M, Fujita K, Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci. 2020, 21:10.3390\/ijms21041447","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1914-3","article-title":"Prostate cancer progression and mortality: a review of diet and lifestyle factors","volume":"35","author":"Peisch SF","year":"2017","unstructured":"Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017, 35:867-74. 10.1007\/s00345-016-1914-3","journal-title":"World J Urol"},{"key":"ref30","article-title":"Obesity and prostate cancer","volume":"13 Suppl 2","author":"O'Malley RL","year":"2006","unstructured":"O'Malley RL, Taneja SS. Obesity and prostate cancer. Can J Urol. 2006, 13 Suppl 2:11-7.","journal-title":"Can J Urol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott EH","year":"2013","unstructured":"Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013, 63:800-9. 10.1016\/j.eururo.2012.11.013","journal-title":"Eur Urol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.167","article-title":"The inflammatory microenvironment and microbiome in prostate cancer development","volume":"15","author":"Sfanos KS","year":"2018","unstructured":"Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol. 2018, 15:11-24. 10.1038\/nrurol.2017.167","journal-title":"Nat Rev Urol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-008-0056-6","article-title":"Prostate cancer and chronic prostatitis","volume":"9","author":"Sandhu JS","year":"2008","unstructured":"Sandhu JS. Prostate cancer and chronic prostatitis. Curr Urol Rep. 2008, 9:328-32. 10.1007\/s11934-008-0056-6","journal-title":"Curr Urol Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2011.11.014","article-title":"Environmental exposures and prostate cancer","volume":"30","author":"Mullins JK","year":"2012","unstructured":"Mullins JK, Loeb S. Environmental exposures and prostate cancer. Urol Oncol. 2012, 30:216-9. 10.1016\/j.urolonc.2011.11.014","journal-title":"Urol Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-020-00583-0","article-title":"Pesticide exposure and risk of aggressive prostate cancer among private pesticide applicators","volume":"19","author":"Pardo LA","year":"2020","unstructured":"Pardo LA, Beane Freeman LE, Lerro CC, et al.. Pesticide exposure and risk of aggressive prostate cancer among private pesticide applicators. Environ Health. 2020, 19:30. 10.1186\/s12940-020-00583-0","journal-title":"Environ Health"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-016-0731-8","article-title":"Childhood height, adult height, and the risk of prostate cancer","volume":"27","author":"Bjerregaard LG","year":"2016","unstructured":"Bjerregaard LG, Aarestrup J, Gamborg M, Lange T, Tj\u00f8nneland A, Baker JL. Childhood height, adult height, and the risk of prostate cancer. Cancer Causes Control. 2016, 27:561-7. 10.1007\/s10552-016-0731-8","journal-title":"Cancer Causes Control"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33150","article-title":"Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category","volume":"147","author":"Jochems SH","year":"2020","unstructured":"Jochems SH, Stattin P, H\u00e4ggstr\u00f6m C, J\u00e4rvholm B, Orho-Melander M, Wood AM, Stocks T. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category. Int J Cancer. 2020, 147:3328-38. 10.1002\/ijc.33150","journal-title":"Int J Cancer"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S71325","article-title":"Vasectomy and prostate cancer risk: a historical synopsis of undulating false causality","volume":"8","author":"Nutt M","year":"2016","unstructured":"Nutt M, Reed Z, K\u00f6hler TS. Vasectomy and prostate cancer risk: a historical synopsis of undulating false causality. Res Rep Urol. 2016, 8:85-93. 10.2147\/RRU.S71325","journal-title":"Res Rep Urol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.21.04511-0","article-title":"Metabolic syndrome and prostate cancer treatment","volume":"64","author":"Morlacco A","year":"2022","unstructured":"Morlacco A, Zattoni F, Soligo M, Lami V, Iafrate M, Zanovello N, Dal Moro F. Metabolic syndrome and prostate cancer treatment. Panminerva Med. 2022, 64:359-64. 10.23736\/S0031-0808.21.04511-0","journal-title":"Panminerva Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000460","article-title":"Nutrition, physical activity, and lifestyle factors in prostate cancer prevention","volume":"28","author":"Ballon-Landa E","year":"2018","unstructured":"Ballon-Landa E, Parsons JK. Nutrition, physical activity, and lifestyle factors in prostate cancer prevention. Curr Opin Urol. 2018, 28:55-61. 10.1097\/MOU.0000000000000460","journal-title":"Curr Opin Urol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12407","article-title":"Prostate cancer: measuring PSA","volume":"44","author":"Pezaro C","year":"2014","unstructured":"Pezaro C, Woo HH, Davis ID. Prostate cancer: measuring PSA. Intern Med J. 2014, 44:433-40. 10.1111\/imj.12407","journal-title":"Intern Med J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000745","article-title":"Progress in prostate cancer prevention","volume":"31","author":"Cozzi G","year":"2022","unstructured":"Cozzi G, Musi G, Ferro M, Cioffi A, de Cobelli O, Corso G. Progress in prostate cancer prevention. Eur J Cancer Prev. 2022, 31:554-7. 10.1097\/CEJ.0000000000000745","journal-title":"Eur J Cancer Prev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/199204-an-in-depth-look-into-the-epidemiological-and-etiological-aspects-of-prostate-cancer-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:55Z","timestamp":1707509395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/199204-an-in-depth-look-into-the-epidemiological-and-etiological-aspects-of-prostate-cancer-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.48252","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,4]]}}}